 |
市场调查报告书
商品编码
1831683
神经学临床试验市场，规模，占有率，趋势，产业分析报告:不同阶段，各种实验设计，各适应症，价值链，各地区，2025年～2034年的市场预测Neurology Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Value Chain, By Region - Market Forecast, 2025-2034 |
||||||
价格
根据 Polaris Market Research 的最新研究，全球神经病学临床试验市场预计到 2034 年将达到 105.9 亿美元。本研究报告深入分析了当前的市场动态和未来的市场成长。
神经病学临床试验市场涉及用于治疗神经系统疾病的新药、疗法和医疗器材的研发。这包括影响大脑、脊髓和周围神经的各种疾病和障碍，例如阿兹海默症、帕金森氏症、癫痫和中风。这些临床试验的主要目的是验证新疗法的安全性和有效性，并提供监管部门批准所需的数据，使公众能够获得这些疗法。
市场成长的驱动力来自全球神经系统疾病数量的增加，以及临床试验技术和服务的进步。日益加重的疾病负担，加上许多疾病治疗选择有限或疗效不佳，导致对新疗法的强烈需求。因此，在公共和私营部门不断增长的投资支持下，大量的研发工作正在进行中。市场概览显示，这是一个复杂且竞争激烈的领域，既包括传统药物研发，也包括基因疗法和个人化医疗等更新、更专业的疗法。
神经病学临床试验市场报告亮点
依阶段划分，2024年III期临床试验将占神经科临床试验市场最大占有率。
依试验设计划分，2024年介入性试验将占最大占有率。这是因为干预性试验透过对受试者进行特定治疗并直接测量其效果，是测试新药和医疗器材的标准方法。
依适应症划分，2024年阿兹海默症将占最大占有率。这是因为疾病影响的患者人数众多，且全球迫切需要有效的治疗方法。
依价值链划分，2024年私人市场将占最大占有率。许多大型製药和生物技术公司拥有内部资源、专业知识和资金，可以自主管理整个临床试验流程，从而确保对研究的全面控制和品质。
按地区划分，预计北美将在2024年占神经病学临床试验市场最大的占有率。这主要归功于其发达的医疗保健体系、大型製药和生技公司的集中，以及针对神经系统疾病的大量研发投入。亚太地区是神经系统疾病领域快速成长的市场。该地区的成长得益于庞大且多元化的患者群体，使得临床试验的患者招募高效且经济。
市场的主要公司包括 IQVIA、ICON plc、Syneos Health、Laboratory Corporation of America Holdings、Charles River Laboratories、Thermo Fisher Scientific、Parexel、Medpace Holdings 以及辉瑞、百健和卫材等製药公司。
目录
第1章 简介
第2章 摘要整理
第3章 调查手法
第4章 全球神经学临床试验市场洞察
- 市场概述
- 神经学临床试验市场动态
- 促进因素和机会
- 神经系统疾病盛行率上升
- 政府资助增加支持
- 阻碍与课题
- 由于复杂性导致临床试验失败率高
- 促进因素和机会
- PESTEL 分析
- 神经科临床试验市场趋势
- 价值链分析
- COVID-19 影响分析
第5章 全球神经学临床试验市场:不同阶段
- 主要调查结果
- 简介
- 阶段I
- 阶段II
- 阶段III
- 阶段IV
第6章 全球神经学临床试验市场:各种实验设计
- 主要调查结果
- 简介
- 干预的
- 观察的
- 扩张存取(点阅)
第7章 全球神经学临床试验市场:各适应症
- 主要调查结果
- 简介
- 阿兹海默症
- 忧郁症(MDD)
- 帕金森氏症(PD)
- 癫痫
- 中风
- 创伤性脑损伤(TBI)
- 肌肉萎缩性脊髓侧索硬化症(ALS)
- 亨丁顿舞蹈症
- 肌肉的再生
- 其他
第8章 全球神经学临床试验市场:价值链
- 主要调查结果
- 简介
- 公司内部
- CRO
- 临床实验实施设施/临床实施设施
第9章 全球神经学临床试验市场:地区
- 主要调查结果
- 简介
- 神经学临床试验市场评估:地区，2020-2034年
- 北美
- 北美:不同阶段，2020～2034年
- 北美:各种实验设计，2020～2034年
- 北美:各适应症，2020～2034年
- 北美:各价值链，2020～2034年
- 美国
- 加拿大
- 欧洲
- 欧洲:不同阶段，2020～2034年
- 欧洲:各种实验设计，2020～2034年
- 欧洲:各适应症，2020～2034年
- 欧洲:各价值链，2020～2034年
- 英国
- 法国
- 德国
- 义大利
- 西班牙
- 荷兰
- 俄罗斯
- 其他欧洲
- 亚太地区
- 亚太地区:不同阶段，2020～2034年
- 亚太地区:各种实验设计，2020～2034年
- 亚太地区:各适应症，2020～2034年
- 亚太地区:各价值链，2020～2034年
- 中国
- 印度
- 马来西亚
- 日本
- 印尼
- 韩国
- 澳洲
- 其他亚太地区
- 中东·非洲
- 中东·非洲:不同阶段，2020～2034年
- 中东·非洲:各种实验设计，2020～2034年
- 中东·非洲:各适应症，2020～2034年
- 中东·非洲:各价值链，2020～2034年
- 沙乌地阿拉伯
- 阿拉伯联合大公国
- 以色列
- 南非
- 其他中东和非洲
- 南美
- 南美:不同阶段，2020～2034年
- 南美:各种实验设计，2020～2034年
- 南美:各适应症，2020-2034年
- 南美:各价值链，2020-2034年
- 墨西哥
- 巴西
- 阿根廷
- 其他南美国家
第10章 竞争情形
- 扩大和收购的分析
- 扩大
- 收购
- 联盟/合作/协定/公开
第11章 企业简介
- Biogen
- Charles River Laboratories
- Eisai Co., Ltd.
- ICON plc
- IQVIA
- Laboratory Corporation of America Holdings
- Medpace Holdings, Inc.
- Parexel
- Pfizer Inc.
- Syneos Health
- Thermo Fisher Scientific
Product Code: PM6420
The global neurology clinical trials market size is expected to reach USD 10.59 billion by 2034, according to a new study by Polaris Market Research. The report "Neurology Clinical Trials Market Size, Share, Trends, Industry Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Value Chain, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The neurology clinical trials market involves the research and development of new drugs, therapies, and medical devices designed to treat conditions of the nervous system. This includes a wide range of diseases and disorders affecting the brain, spinal cord, and peripheral nerves, such as Alzheimer's, Parkinson's, epilepsy, and stroke. The main goal of these trials is to test the safety and effectiveness of new treatments, providing the necessary data for regulatory approval so that new therapies can become available to the public.
The market's growth is largely driven by the increasing number of people worldwide who are affected by neurological disorders, along with clinical trial technology and services. This rising disease burden, combined with the often limited or ineffective treatment options for many conditions, creates a strong demand for new therapies. As a result, there is a lot of research and development happening, supported by growing investments from both private and public sectors. The market's overview shows that it is a complex and competitive field, with a focus on both traditional drug development and newer, more specialized treatments like gene therapies and personalized medicine.
Neurology Clinical Trials Market Report Highlights:
By phase, the phase III segment held the largest share of the neurology clinical trials market in 2024 as these trials are the final and most extensive step before a drug can be submitted for regulatory approval.
By study design, the interventional studies segment held the largest share in 2024. This is due to the fact that these trials are the standard method for testing new drugs and medical devices, as they involve giving a specific treatment to participants and directly measuring its effects.
By indication, the Alzheimer's disease segment held the largest share in 2024. This is because of the large number of people affected by this condition and the urgent global need for effective treatments.
By value chain, the in-house segment held the largest share in 2024 of the market. Many large pharmaceutical and biotech companies have the internal resources, expertise, and funding to manage their entire clinical trial process themselves, giving them full control and ensuring the quality of their research.
By region, North America held the largest share of the neurology clinical trials market in 2024. This is due to its well-developed healthcare system, a high concentration of key pharmaceutical and biotechnology companies, and a significant amount of research and development funding for neurological disorders. The Asia Pacific is a rapidly growing market for neurology clinical trials. The region's growth is driven by its large and diverse patient population, which makes patient recruitment for trials more efficient and cost-effective.
A few key players in the market include IQVIA, ICON plc, Syneos Health, Laboratory Corporation of America Holdings, Charles River Laboratories, Thermo Fisher Scientific, Parexel, Medpace Holdings, and pharmaceutical companies like Pfizer, Biogen, and Eisai Co.
Polaris Market Research has segmented the neurology clinical trials market report based on phase, study design, indication, value chain, and region:
By Phase Outlook (Revenue - USD Billion, 2020-2034)
Phase I
Phase II
Phase III
Phase IV
By Study Design Outlook (Revenue - USD Billion, 2020-2034)
Interventional
Observational
Expanded Access
By Indication Outlook (Revenue - USD Billion, 2020-2034)
Alzheimer's Disease
Depression (MDD)
Parkinson's Disease (PD)
Epilepsy
Stroke
Traumatic Brain Injury (TBI)
Amyotrophic Lateral Sclerosis (ALS)
Huntington's Disease
Muscle Regeneration
Others
By Value Chain Outlook (Revenue - USD Billion, 2020-2034)
In-house
CROs
Investigator Sites/Clinical Sites
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Neurology Clinical Trials Market Insights
- 4.1. Neurology Clinical Trials Market - Market Snapshot
- 4.2. Neurology Clinical Trials Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Prevalence of Neurological Disorders
- 4.2.1.2. Increase in Government Funding and Support
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High trial failure rates due to the complexity
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Neurology Clinical Trials Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Neurology Clinical Trials Market, by Phase
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 5.3. Phase I
- 5.3.1. Global Neurology Clinical Trials Market, by Phase I, by Region, 2020-2034 (USD Billion)
- 5.4. Phase II
- 5.4.1. Global Neurology Clinical Trials Market, by Phase II, by Region, 2020-2034 (USD Billion)
- 5.5. Phase III
- 5.5.1. Global Neurology Clinical Trials Market, by Phase III, by Region, 2020-2034 (USD Billion)
- 5.6. Phase IV
- 5.6.1. Global Neurology Clinical Trials Market, by Phase IV, by Region, 2020-2034 (USD Billion)
6. Global Neurology Clinical Trials Market, by Study Design
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 6.3. Interventional
- 6.3.1. Global Neurology Clinical Trials Market, by Interventional, by Region, 2020-2034 (USD Billion)
- 6.4. Observational
- 6.4.1. Global Neurology Clinical Trials Market, by Observational, by Region, 2020-2034 (USD Billion)
- 6.5. Expanded Access
- 6.5.1. Global Neurology Clinical Trials Market, by Expanded Access, by Region, 2020-2034 (USD Billion)
7. Global Neurology Clinical Trials Market, by Indication
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 7.3. Alzheimer's Disease
- 7.3.1. Global Neurology Clinical Trials Market, by Alzheimer's Disease, by Region, 2020-2034 (USD Billion)
- 7.4. Depression (MDD)
- 7.4.1. Global Neurology Clinical Trials Market, by Depression (MDD), by Region, 2020-2034 (USD Billion)
- 7.5. Parkinson's Disease (PD)
- 7.5.1. Global Neurology Clinical Trials Market, by Parkinson's Disease (PD), by Region, 2020-2034 (USD Billion)
- 7.6. Epilepsy
- 7.6.1. Global Neurology Clinical Trials Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
- 7.7. Stroke
- 7.7.1. Global Neurology Clinical Trials Market, by Stroke, by Region, 2020-2034 (USD Billion)
- 7.8. Traumatic Brain Injury (TBI)
- 7.8.1. Global Neurology Clinical Trials Market, by Traumatic Brain Injury (TBI), by Region, 2020-2034 (USD Billion)
- 7.9. Amyotrophic Lateral Sclerosis (ALS)
- 7.9.1. Global Neurology Clinical Trials Market, by Amyotrophic Lateral Sclerosis (ALS), by Region, 2020-2034 (USD Billion)
- 7.10. Huntington's Disease
- 7.10.1. Global Neurology Clinical Trials Market, by Huntington's Disease, by Region, 2020-2034 (USD Billion)
- 7.11. Muscle Regeneration
- 7.11.1. Global Neurology Clinical Trials Market, by Muscle Regeneration, by Region, 2020-2034 (USD Billion)
- 7.12. Others
- 7.12.1. Global Neurology Clinical Trials Market, by Others, by Region, 2020-2034 (USD Billion)
8. Global Neurology Clinical Trials Market, by Value Chain
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 8.3. In-house
- 8.3.1. Global Neurology Clinical Trials Market, by In-house, by Region, 2020-2034 (USD Billion)
- 8.4. CROs
- 8.4.1. Global Neurology Clinical Trials Market, by CROs, by Region, 2020-2034 (USD Billion)
- 8.5. Investigator Sites/Clinical Sites
- 8.5.1. Global Neurology Clinical Trials Market, by Investigator Sites/Clinical Sites, by Region, 2020-2034 (USD Billion)
9. Global Neurology Clinical Trials Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Neurology Clinical Trials Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Neurology Clinical Trials Market - North America
- 9.3.1. North America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.3.2. North America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.3.3. North America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.3.4. North America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.3.5. Neurology Clinical Trials Market - US
- 9.3.5.1. US: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.3.5.2. US: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.3.5.3. US: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.3.5.4. US: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.3.6. Neurology Clinical Trials Market - Canada
- 9.3.6.1. Canada: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4. Neurology Clinical Trials Market - Europe
- 9.4.1. Europe: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.2. Europe: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.3. Europe: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.4. Europe: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.5. Neurology Clinical Trials Market - UK
- 9.4.5.1. UK: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.6. Neurology Clinical Trials Market - France
- 9.4.6.1. France: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.6.2. France: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.6.3. France: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.6.4. France: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.7. Neurology Clinical Trials Market - Germany
- 9.4.7.1. Germany: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.8. Neurology Clinical Trials Market - Italy
- 9.4.8.1. Italy: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.9. Neurology Clinical Trials Market - Spain
- 9.4.9.1. Spain: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.10. Neurology Clinical Trials Market - Netherlands
- 9.4.10.1. Netherlands: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.11. Neurology Clinical Trials Market - Russia
- 9.4.11.1. Russia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.4.12. Neurology Clinical Trials Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5. Neurology Clinical Trials Market - Asia Pacific
- 9.5.1. Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.5. Neurology Clinical Trials Market - China
- 9.5.5.1. China: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.5.2. China: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.5.3. China: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.5.4. China: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.6. Neurology Clinical Trials Market - India
- 9.5.6.1. India: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.6.2. India: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.6.3. India: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.6.4. India: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.7. Neurology Clinical Trials Market - Malaysia
- 9.5.7.1. Malaysia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.8. Neurology Clinical Trials Market - Japan
- 9.5.8.1. Japan: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.9. Neurology Clinical Trials Market - Indonesia
- 9.5.9.1. Indonesia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.10. Neurology Clinical Trials Market - South Korea
- 9.5.10.1. South Korea: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.11. Neurology Clinical Trials Market - Australia
- 9.5.11.1. Australia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.5.12. Neurology Clinical Trials Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6. Neurology Clinical Trials Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.5. Neurology Clinical Trials Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.6. Neurology Clinical Trials Market - UAE
- 9.6.6.1. UAE: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.7. Neurology Clinical Trials Market - Israel
- 9.6.7.1. Israel: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.8. Neurology Clinical Trials Market - South Africa
- 9.6.8.1. South Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.6.9. Neurology Clinical Trials Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7. Neurology Clinical Trials Market - Latin America
- 9.7.1. Latin America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7.5. Neurology Clinical Trials Market - Mexico
- 9.7.5.1. Mexico: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7.6. Neurology Clinical Trials Market - Brazil
- 9.7.6.1. Brazil: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7.7. Neurology Clinical Trials Market - Argentina
- 9.7.7.1. Argentina: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- 9.7.8. Neurology Clinical Trials Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Biogen
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Charles River Laboratories
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Eisai Co., Ltd.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. ICON plc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. IQVIA
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Laboratory Corporation of America Holdings
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Medpace Holdings, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Parexel
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Pfizer Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Syneos Health
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Thermo Fisher Scientific
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
List of Tables:
- Table 1 Global Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 2 Global Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 3 Global Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 4 Global Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 5 North America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 6 North America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 7 North America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 8 North America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 9 U.S.: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 10 U.S.: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 11 U.S.: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 12 U.S.: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 13 Canada: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 14 Canada: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 15 Canada: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 16 Canada: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 17 Europe: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 18 Europe: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 19 Europe: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 20 Europe: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 21 UK: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 22 UK: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 23 UK: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 24 UK: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 25 France: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 26 France: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 27 France: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 28 France: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 29 Germany: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 30 Germany: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 31 Germany: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 32 Germany: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 33 Italy: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 34 Italy: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 35 Italy: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 36 Italy: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 37 Spain: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 38 Spain: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 39 Spain: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 40 Spain: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 41 Netherlands: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 42 Netherlands: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 43 Netherlands: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 44 Netherlands: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 45 Russia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 46 Russia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 47 Russia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 48 Russia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 49 Rest of Europe: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 50 Rest of Europe: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 51 Rest of Europe: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 52 Rest of Europe: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 53 Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 54 Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 55 Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 56 Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 57 China: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 58 China: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 59 China: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 60 China: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 61 India: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 62 India: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 63 India: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 64 India: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 65 Malaysia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 66 Malaysia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 67 Malaysia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 68 Malaysia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 69 Japan: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 70 Japan: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 71 Japan: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 72 Japan: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 73 Indonesia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 74 Indonesia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 75 Indonesia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 76 Indonesia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 77 South Korea: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 78 South Korea: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 79 South Korea: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 80 South Korea: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 81 Australia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 82 Australia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 83 Australia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 84 Australia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 85 Rest of Asia Pacific: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 86 Rest of Asia Pacific: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 87 Rest of Asia Pacific: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 88 Rest of Asia Pacific: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 89 Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 90 Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 91 Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 92 Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 93 Saudi Arabia: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 94 Saudi Arabia: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 95 Saudi Arabia: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 96 Saudi Arabia: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 97 UAE: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 98 UAE: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 99 UAE: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 100 UAE: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 101 Israel: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 102 Israel: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 103 Israel: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 104 Israel: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 105 South Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 106 South Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 107 South Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 108 South Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 109 Rest of Middle East & Africa: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 110 Rest of Middle East & Africa: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 111 Rest of Middle East & Africa: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 112 Rest of Middle East & Africa: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 113 Latin America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 114 Latin America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 115 Latin America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 116 Latin America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 117 Mexico: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 118 Mexico: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 119 Mexico: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 120 Mexico: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 121 Brazil: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 122 Brazil: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 123 Brazil: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 124 Brazil: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 125 Argentina: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 126 Argentina: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 127 Argentina: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 128 Argentina: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
- Table 129 Rest of Latin America: Neurology Clinical Trials Market, by Phase, 2020-2034 (USD Billion)
- Table 130 Rest of Latin America: Neurology Clinical Trials Market, by Study Design, 2020-2034 (USD Billion)
- Table 131 Rest of Latin America: Neurology Clinical Trials Market, by Indication, 2020-2034 (USD Billion)
- Table 132 Rest of Latin America: Neurology Clinical Trials Market, by Value Chain, 2020-2034 (USD Billion)
List of Figures:
- Figure 1. Global Neurology Clinical Trials Market, 2020-2034 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Price
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Phase
- Figure 7. Global Neurology Clinical Trials Market, by Phase, 2024 & 2034 (USD Billion)
- Figure 8. Market by Study Design
- Figure 9. Global Neurology Clinical Trials Market, by Study Design, 2024 & 2034 (USD Billion)
- Figure 10. Market by Indication
- Figure 11. Global Neurology Clinical Trials Market, by Indication, 2024 & 2034 (USD Billion)
- Figure 12. Market by Value Chain
- Figure 13. Global Neurology Clinical Trials Market, by Value Chain, 2024 & 2034 (USD Billion)
